Dhampur Bio Organics Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	20,338	18,615	18,644	24,075	15,641	-
Revenue Growth (YoY)	9.33%	-0.16%	-22.56%	53.92%	-	-
Cost of Revenue	15,661	14,218	14,027	18,580	11,718	-
Gross Profit	4,677	4,398	4,617	5,495	3,923	-
Selling, General & Admin	1,122	1,042	1,005	1,109	750.5	-
Other Operating Expenses	2,221	1,990	2,184	2,221	1,261	0.24
Operating Expenses	3,944	3,570	3,684	3,735	2,324	0.24
Operating Income	732.9	827.2	933.1	1,760	1,599	-0.24
Interest Expense	-641.1	-645.5	-433.6	-380.8	-294.2	-
Interest & Investment Income	15.9	15.9	23.1	4.8	5.2	-
Currency Exchange Gain (Loss)	-0.6	-0.6	14.1	-7.2	-0.1	-
Other Non Operating Income (Expenses)	188.6	-25.5	-19.7	-27.6	-2.7	-
EBT Excluding Unusual Items	295.7	171.5	517	1,349	1,307	-0.24
Merger & Restructuring Charges	-	-	-	-2	-30	-
Gain (Loss) on Sale of Assets	3.2	3.2	137.9	0.3	16.7	-
Other Unusual Items	-	-17.6	-	-	-	-
Pretax Income	298.9	157.1	654.9	1,348	1,294	-0.24
Income Tax Expense	61.8	10.2	190	236.7	270.8	-
Net Income	237.1	146.9	464.9	1,111	1,023	-0.24
Net Income to Common	237.1	146.9	464.9	1,111	1,023	-0.24
Net Income Growth	154.95%	-68.40%	-58.16%	8.57%	-	-
Shares Outstanding (Basic)	66	66	66	66	66	-
Shares Outstanding (Diluted)	66	66	66	66	66	-
EPS (Basic)	3.58	2.21	7.00	16.74	15.41	-
EPS (Diluted)	3.58	2.21	7.00	16.74	15.41	-
EPS Growth	155.99%	-68.40%	-58.16%	8.57%	-	-
Free Cash Flow	-	-161.7	-2,720	1,448	-4,078	-0.24
Free Cash Flow Per Share	-	-2.44	-40.98	21.81	-61.43	-
Dividend Per Share	-	1.250	2.500	3.500	-	-
Dividend Growth	-	-50.00%	-28.57%	-	-	-
Gross Margin	23.00%	23.62%	24.76%	22.82%	25.08%	-
Operating Margin	3.60%	4.44%	5.00%	7.31%	10.22%	-
Profit Margin	1.17%	0.79%	2.49%	4.61%	6.54%	-
Free Cash Flow Margin	-	-0.87%	-14.59%	6.01%	-26.07%	-
EBITDA	1,264	1,326	1,388	2,133	1,889	-
EBITDA Margin	6.22%	7.12%	7.45%	8.86%	12.07%	-
D&A For EBITDA	531.58	498.8	455.1	373.2	289.5	-
EBIT	732.9	827.2	933.1	1,760	1,599	-0.24
EBIT Margin	3.60%	4.44%	5.00%	7.31%	10.22%	-
Effective Tax Rate	20.68%	6.49%	29.01%	17.56%	20.93%	-
Revenue as Reported	30,876	26,966	24,183	26,659	15,718	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.